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Abstract The addition of leucine induced activation of p70S6k
in amino acid-depleted H4IIE cells. Whereas the activation of
p70S6k by leucine was transient, the complete amino acid
stimulated p70S6k more persistently. The effect of leucine on
p70S6k was sensitive to rapamycin, but less sensitive to
wortmannin. Using various amino acids and derivatives of
leucine, we found that the chirality, the structure of the four
branched hydrocarbons, and the primary amine are required for
the ability of leucine to stimulate p70S6k, indicating that the
structural requirement of leucine to induce p70S6k activation is
very strict and precise. In addition, some leucine derivatives
exhibited the ability to stimulate p70S6k and the other derivatives
acted as inhibitors against the leucine-induced activation of
p70S6k.
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1. Introduction
Amino acids represent a large group of mutually analogous
nutrients. They compose proteins, which perform a wide vari-
ety of important functions, such as serving as structural com-
ponents of cells and tissues, an energy source at the skeletal
muscles, and acting as protein hormones, antibodies, and en-
zymes [1]. Another critical role of amino acids is the regula-
tion of translational e¡ectors, including p70 S6 kinase
(p70S6k), and eIF-4E binding protein1/PHAS1 (4E-BP1) [2^8].
p70S6k is activated through multisite phosphorylation in
response to insulin/mitogen and phosphorylates 40S riboso-
mal protein S6 in vivo [9]. This protein kinase has been shown
to play a critical role in regulating selective translation of
mRNAs that contain a polypyrimidine tract at their 5P end
[10,11]. 4E-BP1 binds to the 7-methylguanosine cap-binding
protein eIF-4E, and prevents eIF-4E from binding to p220/
eIF-4G [12]. Mitogens stimulate the phosphorylation of 4E-
BP1, resulting in its dissociation from eIF-4E [13], and this
makes eIF-4E available for incorporation into the translation-
al initiation complex and restoring translation [14].
p70S6k and 4E-BP1 are both dephosphorylated in vivo in
response to the macrolide immunosuppressant rapamycin
[15,16]. This compound binds to FKBP12 and FKBP12-rapa-
mycin forms complex with the target of rapamycin (desig-
nated mTOR, also named FRAP, RAFT-1, and RAPT-1)
[15,17]. The protein kinase activity of mTOR is inhibited by
the binding of FKBP12-rapamycin [17]. Recent studies have
revealed that mTOR is an upstream regulator of p70S6k and
4E-BP1 [17^19].
More recently, the phosphorylation and the activation of
p70S6k and 4E-BP1 in vivo has been reported to be governed
by the availability of amino acids [2^8]. Our previous study
resulted in the following observations [3]: (i) while amino acid
withdrawal diminishes p70S6k activity and phosphorylation of
4E-BP1 in CHO-IR cells and HEK293 cells, amino acid re-
pletion restores these responses; (ii) these e¡ects of amino acid
repletion are blocked by rapamycin; (iii) the p70S6k mutant,
p70v2^46/vCT104, which is resistant to rapamycin, is also
insensitive to inhibition by amino acid withdrawal. These re-
sults suggest that amino acids control p70S6k and 4E-BP1
through a mechanism involving the mTOR signaling pathway.
In the present study, we examined the ability of individual
amino acids to stimulate p70S6k activation using H4IIE rat
hepatoma cells, in which we have previously shown that the
addition of amino acids activates p70S6k and 4E-BP1 and that
amino acid depletion from the culture medium can cause the
generation of amino acids endogenously through autophagy,
a major mechanism of facultative protein degradation in the
liver [8]. We showed that the addition of leucine alone after
withdrawal of medium amino acid stimulates p70S6k activity.
Then using various derivatives of leucine, we further explored
which structural characteristics are required to stimulate
p70S6k activity.
2. Materials and methods
2.1. Reagents and antibodies
Minimal essential medium K (KMEM) and fetal calf serum (FCS)
were purchased from Gibco BRL. Amino acid-deprived medium was
prepared by mixing all ingredients contained in Dulbecco’s modi¢ed
Eagle’s medium (DMEM) except for amino acids. Protein G-Sephar-
ose 4FF was from Pharmacia. [Q-32P]ATP was purchased from Amer-
sham. Wortmannin was purchased from Sigma. Rapamycin was pur-
chased from Calbiochem. Amino acids were purchased from Wako.
Derivatives of leucine were from Bachem. The polyclonal antiserum
against the C-terminal 104 amino acids of p70S6k (p70S6kCT Ab) used
for immunoprecipitation of endogenous p70S6k was a generous gift
from Dr. Joseph Avruch (The Diabetes Unit, Massachusetts General
Hospital).
2.2. Cell culture and treatments
Rat hepatoma H4IIE cells were grown in KMEM with 10% FCS.
Cells were ¢rst incubated in KMEM without FCS for 24 h, washed
once with amino acid-deprived medium and incubated in the same
medium for 2 h. Then, the cells were incubated with the media con-
taining various amino acids or amino acid derivatives as indicated in
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each experiment. The concentration of each amino acid except for
tryptophan designated 1U is equivalent to that found in perfusate
basal plasma of rat [20] as follows (in WM): arginine, 220; cystine,
34; glutamine, 716; histidine, 92; isoleucine, 114; leucine, 204; lysine,
408; methionine, 60; phenylalanine, 96; proline, 437; serine, 657;
threonine, 329; tyrosine, 98; valine, 250. The concentration of tryp-
tophan in DMEM (78 WM) is employed as 1U concentration. A
mixture of all these amino acids, each at this concentration, is desig-
nated the ‘complete amino acid mixture at 1U concentration’. As a
reference, the concentration of each amino acid contained in KMEM
was as follows (in WM); alanine, 281; arginine, 603; asparagine, 333;
aspartic acid, 225; cystine, 99; cysteine, 569; glutamic acid, 510;
glutamine, 1998; glycine, 666; histidine, 200; isoleucine, 396; leucine,
396; lysine,400; methionine, 101; phenylalanine, 194; proline, 347;
serine, 238; threonine, 403; tryptophan, 49; tyrosine, 287; valine,
393. Treatment of cells was terminated by removal of the medium,
followed by freezing with liquid nitrogen; then cells were stored at
380‡C until use. Cells were extracted into ice-cold bu¡er A (50 mM
Tris-HCl at pH 8.0, 1% Nonidet P-40, 120 mM NaCl, 20 mM NaF,
1 mM EDTA, 6 mM EGTA, 20 mM L-glycerophosphate, 0.5 mM
dithiothreitol, 50 WM p-amidinophenylmethylsulfonyl £uoride hydro-
chloride, 1 Wg/ml aprotinin, 1 Wg/ml leupeptin), and the extracts were
centrifuged at 10 000Ug for 20 min at 4‡C prior to analysis.
2.3. Immunoprecipitation and p70 S6 kinase assays
The p70S6k activity was determined in the immunoprecipitates using
40S ribosomal subunits as substrate. Cells were lysed in ice-cold bu¡er
A, and the extracts were centrifuged at 10 000Ug for 20 min at 4‡C.
Aliquots of the supernatants were subjected to immunoprecipitation
with p70S6kCT Ab for 2 h, absorbed to protein G Sepharose 4FF,
washed twice with bu¡er A containing 0.5 M NaCl, and twice with
wash bu¡er (20 mM MOPS at pH 7.2, 10 mM L-glycerophosphate).
The 40S S6 protein kinase assay was started by adding the reaction
mixture (50 mM MOPS at pH 7.2, 12 mM MgCl2, 2 mM EGTA,
1 mM dithiothreitol, 60 WM ATP, 10 mM L-glycerophosphate, 0.5 WM
protein kinase inhibitor, 0.5 A260 units of 40S ribosomal subunits,
5 WCi of [Q-32P]ATP), incubated for 20 min at 30‡C, and terminated
by adding the SDS sample bu¡er. The samples were separated by
SDS-PAGE on 12% acrylamide gel, and the radioactivity incorpo-
rated into 40S S6 protein of each sample was quantitated with
BAS-2000 Bioimaging analyzer (Fuji).
3. Results and discussion
3.1. Leucine stimulates p70S6k activity in amino acid-depleted
cells
The ability of individual amino acids to stimulate p70S6k
activity following amino acid withdrawal was examined using
H4IIE cells. As shown in Table 1A, the readdition of the
complete amino acid mixture at 4U concentration to the ami-
no acid-depleted cells stimulated p70S6k activity up to 5-fold
compared to control. Among the amino acids, leucine and
methionine at 4U concentration enhanced p70S6k activity 6-
and 2.4-fold, respectively. However, the addition of the other
amino acids did not stimulate p70S6k activity signi¢cantly. As
with p70S6k, leucine at 4U concentration stimulated 4E-BP1
phosphorylation (data not shown). Consistent with our obser-
vations, the other reports have demonstrated that the read-
dition of leucine alone after amino acid withdrawal activates
p70S6k activity in FAO hepatoma cells [5] and 4E-BP1 phos-
phorylation in isolated adipocytes [21] and pancreatic L-cells
[22]. Xu et al. has shown that valine and isoleucine, as well as
leucine, are capable of stimulating the phosphorylation of 4E-
BP1 in pancreatic L-cells [22]. The concentrations of branched
amino acids they employed were 4^10 mM, which is 10^20
times higher than those used in the present study. The con-
centrations of amino acids we used are much closer to those
found in physiological conditions [20]. Stimulation of p70S6k
activity by leucine was observed in a time- and dose-depend-
ent manner, as shown in Figs. 1A and 1B. The p70S6k activity
reached a maximum at 20 min after the addition of leucine at
4U concentration and then gradually decreased. On the other
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Table 1
Stimulation of p70S6k activity by individual amino acids and leucine
derivatives in amino acid-depleted cells
Amino acid p70S6k activity (%)
None 18 þ 5.6
(A)
Complete amino acids 100
L-Leucine 120 þ 28
L-Methionine 47 þ 2.2
L-Histidine 27 þ 3.0
L-Glutamine 24 þ 8.7
L-Valine 21 þ 0.34
L-Arginine 20 þ 9.8
L-Tyrosine 20 þ 5.6
L-Proline 20 þ 1.6
L-Isoleucine 17 þ 6.1
L-Threonine 16 þ 2.3
L-Lysine 14 þ 0.13
L-Tryptophan 15 þ 2.5
L-Phenylalanine 13 þ 1.3
L-Cystine 12 þ 3.2
(B)
L-Leucine 100
D-Leucine 20 þ 1.2
Ac-Leu-OH 19 þ 3.2
N-Me-Leu-OH 13 þ 4.9
H-Leu-NH2cHCl 250 þ 4.6
Ac-Leu-NH2 17 þ 4.2
Ac-Leu-NHMe 11 þ 0.76
H-K-Me-DL-Leu-OH 140 þ 6.3
After serum starvation for 24 h, H4IIE cells were incubated with
amino acid-deprived medium for 2 h. The cells were incubated for
another 20 min with amino acid-depleted medium (None), the me-
dium containing the complete amino acid mixture at 4U concentra-
tion (Complete amino acids), each amino acid at 4U concentration
(A) or various leucine derivatives at 4U concentration (B). p70S6k
activity was determined as described in Section 2. The activity in
the cells treated with complete amino acids at 4U concentration (A)
or L-leucine at 4U concentration (B) was used as 100%. Data are
means þ S.D. of triplicates.
Fig. 1. Stimulation of p70S6k activity by the addition of leucine in
amino acid-depleted cells. After serum starvation for 24 h, H4IIE
cells were incubated with amino acid-deprived medium for 2 h. A:
The cells were then incubated with amino acid-deprived medium in
the presence (closed circles) or absence (open circles) of leucine at
4U concentration (1U= 204 WM), or complete medium at 4U con-
centration (open squares) for the indicated times. B: The cells were
incubated with amino acid-deprived medium containing various con-
centrations of leucine for 20 min. p70S6k activity was determined as
described in Section 2, and expressed in arbitrary units (photostimu-
lated luminescence (PSL) units). Data are the means þ S.D. of tripli-
cates.
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hand, the complete amino acid at 4U concentration stimu-
lated the p70S6k activation more persistently and kept stimu-
lating up to 30^60 min. Thus, some other amino acids appear
to play a role in inducing persistent p70S6k activation in con-
cert with leucine.
3.2. E¡ects of wortmannin and rapamycin on leucine-induced
p70S6k activation
We next examined the upstream inputs required for the
leucine-induced p70S6k activation. H4IIE cells were subjected
to amino acid withdrawal for 2 h, and pretreated with either
the phosphoinositide 3-kinase (PI3-k) inhibitor, wortmannin
or the mTOR kinase inhibitor, rapamycin prior to stimulation
with leucine (Fig. 2A, lanes 3 and 4). The activation of p70S6k
by leucine was strongly inhibited by 100 nM rapamycin, and
moderately altered by 100 nM wortmannin. The leucine-in-
duced increase in p70S6k activity was inhibited completely at
1000 nM wortmannin (Fig. 2B) and at 0.3^1.0 nM rapamycin
(Fig. 2C). The sensitivities of leucine-activated p70S6k to wort-
mannin and rapamycin were similar to those of amino acid-
activated p70S6k to these agents as described previously in
H4IIE cells [9]. As with p70S6k, the ability of leucine at 4U
concentration to stimulate 4E-BP1 phosphorylation was sen-
sitive to rapamycin, but much less sensitive to wortmannin
(data not shown). Thus, these observations suggest that leu-
cine induces p70S6k activation and 4E-BP1 phosphorylation in
H4IIE cells through amino acid-mediated signaling, and leu-
cine plays a critical role in amino acid-induced p70S6k activa-
tion and 4E-BP1 phosphorylation.
3.3. The structural requirement of leucine for activation of
p70S6k
The present data shown in Table 1A clearly indicate that
hydrophilic side chains (such as glutamine, arginine, and ly-
sine) and aromatic side chains (such as histidine, tyrosine,
tryptophan and phenylalanine) are not required to activate
p70S6k. Among aliphatic side chains, the structure of the
four branched hydrocarbons of leucine is critical for the abil-
ity of leucine to activate p70S6k. However, the other branched-
chain amino acids, such as valine and isoleucine, failed to
activate p70S6k in H4IIE cells.
In order to further analyze the structural requirement of
leucine for the activation of p70S6k, we employed the follow-
ing leucine derivatives (Fig. 3): (a) the optical isomer of L-
leucine, D-leucine; (b) leucine with its modi¢ed amino group,
N-acetylleucine (Ac-Leu-OH) and N-methylleucine (N-Me-
Leu-OH); (c) leucine with its modi¢ed carboxyl group, leucine
amide hydrochloride (H-Leu-NH2cHCl); (d) leucine with its
modi¢ed amino and carboxyl groups, N-acetylleucine amide
(Ac-Leu-NH2) and N-acetylleucine N-methylamide (Ac-Leu-
NHMe); (e) leucine with its modi¢ed K-hydrogen atom: K-
methyl-DL-leucine (H-K-Me-DL-Leu-OH), which is a mixture
of D- and L-isomers (1:1 molar ratio). After amino acid with-
drawal for 2 h, H4IIE cells were treated with each of these
leucine derivatives at 4U concentration. As shown in Table
1B, (i) D-leucine, the optical isomer of L-leucine, did not acti-
vate p70S6k ; (ii) modi¢cation of the amino group (Ac-Leu-
OH, N-Me-Leu-OH, Ac-Leu-NH2, and Ac-Leu-NHMe) abol-
ished the ability of leucine to activate p70S6k ; (iii) modi¢cation
of the carboxyl group (H-Leu-NH2cHCl) conserved the ability
of leucine to activate p70S6k ; (iv) modi¢cation of the K-hydro-
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Fig. 2. E¡ects of wortmannin and rapamycin on the leucine-induced
p70S6k activation in amino acid-depleted cells. A: After serum star-
vation for 24 h, H4IIE cells were incubated with amino acid-de-
prived medium for 2 h. The cells were then incubated for another
20 min with either amino acid-deprived medium (lane 1) or medium
containing leucine at 4U concentration (lanes 2^4). Prior to the ad-
dition of leucine, the cells were pretreated for 30 min with vehicle
(lane 2), 100 nM wortmannin (lane 3), or 100 nM rapamycin (lane
4). p70S6k activity was determined as described in Section 2. Num-
bers at the top of each lane represent 32P incorporated into S6 ex-
pressed as a percentage of that catalyzed by p70S6k immunoprecipi-
tated from cell extracts treated with leucine at 4U concentration
following amino acid withdrawal (lane 2). B and C: After serum
starvation for 24 h, H4IIE cells were incubated with amino acid-de-
prived medium for 2 h (open squares). The cells were then incu-
bated for another 20 min with amino acid-deprived medium con-
taining leucine at 4U concentration (open circles). Prior to the
addition of leucine, cells were pretreated with the indicated concen-
trations of wortmannin (B) or rapamycin (C) for 30 min. p70S6k ac-
tivity was determined as described in Section 2. p70S6k activity in
the cells without pretreatment was used as 100%. Data are the
means þ S.D. of triplicates.
Fig. 3. Structures of leucine derivatives. Formal nomenclatures and
abbreviations (in parentheses) are shown.
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gen (H-K-Me-DL-Leu-OH) also did not abolish the ability of
leucine to activate p70S6k. Thus, these results suggest the fol-
lowing points: (i) the chirality (stereoselectivity) is critical ; (ii)
the primary amine of leucine is also quite important, which is
based on the results of the diminished ability of N-Me-Leu-
OH; (iii) the carboxyl group and the K-hydrogen of leucine
are not critical.
3.4. Inhibitory e¡ects of Ac-Leu-NH2 and Ac-Leu-NHMe on
the leucine-induced p70S6k activation
The e¡ects of leucine derivatives, Ac-Leu-NH2 and Ac-Leu-
NHMe, that do not stimulate p70S6k activity were examined
on the leucine-induced p70S6k activation. Among these deriv-
atives, Ac-Leu-NH2 exhibited slightly stimulatory e¡ects at
the lower concentration and inhibitory at the higher concen-
trations on the leucine-induced p70S6k activation (Fig. 4A).
Ac-Leu-NHMe strongly inhibited the leucine-induced p70S6k
activation in a dose-dependent manner (Fig. 4B). Both leucine
derivatives exhibited maximum inhibition of the leucine-in-
duced p70S6k activation at an approximately 30 times higher
concentration than that of leucine used to activate p70S6k.
These derivatives would be a good tool to control various
cellular events, which are known to be regulated by amino
acids and/or leucine.
3.5. Conclusion
Using various amino acids and derivatives of leucine, we
found that the chirality (stereo-activity), the structure of the
four branched hydrocarbons of leucine, and the primary
amine of leucine are required to stimulate p70S6k activity. In
addition, some leucine derivatives exhibited the ability to
stimulate p70S6k, and the other derivatives lacked this ability,
rather acting as inhibitors against the leucine-induced activa-
tion of p70S6k.
The mechanism of the leucine-induced p70S6k activation
remains to be elucidated. If there does exist an acceptor mol-
ecule(s) speci¢c to leucine, the recognition of this acceptor by
leucine should be very strict and precise. The system L amino
acid transporter has been known to incorporate isoleucine,
valine, methionine, phenylalanine, histidine, and 2-(3)-endo-
amino-bicycloheptane-2-carboxylic acid from the medium to
the intracellular space as well as leucine [23]. Because the
structural requirement of these amino acids by the system L
transporter is not strict, the system L transporter might not be
a candidate for the acceptor protein for leucine to induce the
activation of p70S6k.
Further analysis of the leucine-induced activation of trans-
lational e¡ectors will reveal the mechanism of cellular events
mediated by the mTOR signaling pathway, such as mRNA
translation, autophagy, and proliferation of T cells.
Acknowledgements: This work was supported in part by research
grants from the Ministry of Education, Science, Sports and Culture
of Japan and the Sankyo Foundation of Life Science. We are grateful
to Dr. Y. Nishizuka for encouragement and Drs. J. Avruch and U.
Kikkawa for valuable advice. The skilful secretarial assistance of M.
Kusu is cordially acknowledged.
References
[1] Cooper, G.M. (1997) in: The Cell: A Molecular Approach, pp.
39^85, American Society for Microbiology, Washington, DC.
[2] Svanberg, E., Je¡erson, L.S., Lundholm, K. and Kimball, S.R.
(1997) Am. J. Physiol. 272, E841^847.
[3] Hara, K., Yonezawa, K., Weng, Q.P., Kozlowski, M.T., Belham,
C. and Avruch, J. (1998) J. Biol. Chem. 273, 14484^14494.
[4] Xu, G., Marshall, C.A., Lin, T.A., Kwon, G., Munivenkatappa,
R.B., Hill, J.R., Lawrence Jr., J.C. and McDaniel, M.L. (1998)
J. Biol. Chem. 273, 4485^4491.
[5] Patti, M.E., Brambilla, E., Luzi, L., Landaker, E.J. and Kahn,
C.R. (1998) J. Clin. Invest. 101, 1519^1529.
[6] Fox, H., Kimball, S., Je¡erson, L. and Lynch, C. (1998) Am. J.
Physiol. 274, C206^213.
[7] Wang, X., Campbell, L., Miller, C. and Proud, C. (1998) Bio-
chem. J. 334, 261^267.
[8] Shigemitsu, K., Tsujishita, Y., Hara, K., Nanahoshi, M., Avruch,
J. and Yonezawa, K. (1999) J. Biol. Chem. 274, 1058^1065.
[9] Avruch, J. (1998) Mol. Cell. Biochem. 182, 31^48.
[10] Je¡eries, H.B., Fumagalli, S., Dennis, P.B., Reinhard, C., Pear-
son, R.B. and Thomas, G. (1997) EMBO J. 16, 3693^3704.
[11] Terada, N., Patel, H.R., Takase, K., Kohno, K., Nairn, A.C. and
Gelfand, E.W. (1994) Proc. Natl. Acad. Sci. USA 91, 11477^
11481.
[12] Haghighat, A., Mader, S., Pause, A. and Sonenberg, N. (1995)
EMBO J. 14, 5701^5709.
[13] Pause, A., Belsham, G.J., Gingras, A.C., Donze, O., Lin, T.A.,
Lawrence Jr., J.C. and Sonenberg, N. (1994) Nature 371, 762^
767.
[14] Sonenberg, N. (1996) in: Translational Control (Hershey, J.W.B.,
Mathews, M.B. and Sonenberg, N., Eds), pp. 245^270, Cold
Spring Harbor Laboratory, Cold Spring Harbor, NY.
[15] Abraham, R.T. and Wiederrecht, G.J. (1996) Annu. Rev. Immu-
nol. 14, 483^510.
[16] Hall, M.N. (1996) Biochem. Soc. Trans. 24, 234^239.
[17] Brown, E.J., Beal, P.A., Keith, C.T., Chen, J., Shin, T.B. and
Schreiber, S.L. (1995) Nature 377, 441^446.
[18] Hara, K., Yonezawa, K., Kozlowski, M.T., Sugimoto, T., An-
drabi, K., Weng, Q.P., Kasuga, M., Nishimoto, I. and Avruch, J.
(1997) J. Biol. Chem. 272, 26457^26463.
[19] Brunn, G.J., Hudson, C.C., Sekulic, A., Williams, J.M., Hosoi,
H., Houghton, P.J., Lawrence Jr., J.C. and Abraham, R.T.
(1997) Science 277, 99^101.
[20] Mortimore, G.E., Poso, A.R., Kadowaki, M. and Wert, J.J.J.
(1987) J. Biol. Chem. 262, 16322^16327.
[21] Fox, H.L., Pham, P.T., Kimball, S.R., Je¡erson, L.S. and Lynch,
C.J. (1998) Am. J. Physiol. 275, C1232^1238.
[22] Xu, G., Kwon, G., Marshall, C.A., Lin, T.A., Lawrence Jr., J.C.
and McDaniel, M.L. (1998) J. Biol. Chem. 273, 28178^28184.
[23] Christiansen, H.N. (1990) Physiol. Rev. 70, 43^71.
FEBS 21772 22-3-99
Fig. 4. E¡ects of leucine derivatives on the leucine-induced p70S6k
activation in the amino acid-depleted cells. After serum starvation
for 24 h, H4IIE cells were incubated with amino acid-deprived me-
dium for 2 h (open squares). The cells were then incubated for 20
min with amino acid-deprived medium containing leucine at 4U
concentration in the presence of Ac-Leu-NH2 (A) or Ac-Leu-NHMe
(B) at the indicated concentrations relative to the concentration of
leucine (open circles). p70S6k activity was determined as described in
Section 2. p70S6k activity stimulated with leucine at 4U concentra-
tion in the absence of leucine derivatives was used as 100%. Data
are the means þ S.D. of triplicates.
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